Ascentage Pharma Group International (AAPG) Total Current Liabilities (2023 - 2025)
Historic Total Current Liabilities for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $173.0 million.
- Ascentage Pharma Group International's Total Current Liabilities changed N/A to $173.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $173.0 million, marking a year-over-year change of. This contributed to the annual value of $159.8 million for FY2024, which is 2090.76% up from last year.
- Ascentage Pharma Group International's Total Current Liabilities amounted to $173.0 million in Q2 2025.
- Over the past 5 years, Ascentage Pharma Group International's Total Current Liabilities peaked at $173.0 million during Q2 2025, and registered a low of $129.7 million during Q4 2023.
- In the last 3 years, Ascentage Pharma Group International's Total Current Liabilities had a median value of $162.4 million in 2024 and averaged $155.1 million.
- Within the past 5 years, the most significant YoY rise in Ascentage Pharma Group International's Total Current Liabilities was 2517.69% (2024), while the steepest drop was 2517.69% (2024).
- Quarter analysis of 3 years shows Ascentage Pharma Group International's Total Current Liabilities stood at $129.7 million in 2023, then increased by 25.18% to $162.4 million in 2024, then increased by 6.52% to $173.0 million in 2025.
- Its Total Current Liabilities was $173.0 million in Q2 2025, compared to $162.4 million in Q4 2024 and $129.7 million in Q4 2023.